# 静脉注射设备市场

> 静脉设备市场研究报告按类型（输液泵、静脉导管、静脉给药装置、针头、静脉容器）、按应用（化疗、疼痛管理、抗生素治疗、液体复苏、营养支持）、按最终用途（医院、门诊手术中心、家庭护理环境、专科诊所）、按技术（电机械泵、重力输液系统、智能静脉治疗系统）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 3.82%
- **2024:** $ 31.94 Billion
- **2025:** $ 33.16 Billion
- **2035:** $ 48.25 Billion
- **Key Players:** Baxter International Inc (US), B. Braun Melsungen AG (DE), Fresenius Kabi AG (DE), Smiths Medical (US), Terumo Corporation (JP), Medtronic plc (IE), Vygon S.A. (FR), ICU Medical, Inc. (US), Halyard Health, Inc. (US)

**Report ID:** MRFR/HC/30895-HCR · **Pages:** 128 · **Author:** Nidhi Mandole & Kinjoll Dey · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/intravenous-equipment-market-32694

---

## Market Summary

## **Intravenous Equipment Market Overview**

As per MRFR analysis, the Intravenous Equipment Market Size was estimated at 31.94 (USD Billion) in 2024. The Intravenous Equipment Market Industry is expected to grow from 33.16 (USD Billion) in 2025 to 46.47 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 3.82% during the forecast period (2025 - 2034).

### **Key Intravenous Equipment Market Trends Highlighted**

The Intravenous Equipment Market is experiencing several notable trends driven by various factors. A key market driver is the increasing prevalence of chronic diseases, which leads to a higher demand for intravenous therapy. Additionally, the rising elderly population requires more healthcare services, adding to the need for intravenous equipment. Advances in technology are also playing a significant role, as innovations in devices improve safety and efficacy in patient care. Opportunities exist for market participants to expand their product offerings, especially in developing regions where healthcare infrastructure is evolving. 

There is also potential in enhancing the integration of smart technologies within intravenous equipment to optimize patient monitoring and medication delivery.As healthcare providers increasingly focus on patient-centric solutions, there is a growing demand for equipment that improves the overall patient experience and reduces the likelihood of complications. In recent times, there is a noticeable shift toward single-use devices to minimize the risk of infections, aligning with stricter regulatory standards. The trend of customization in intravenous equipment is gaining traction as healthcare facilities aim to tailor solutions to meet specific patient needs. 

Moreover, the rise of telemedicine has led to more remote patient monitoring, creating a demand for portable intravenous systems. This evolution reflects a broader drive toward more comprehensive, efficient, and safer healthcare solutions, emphasizing the importance of intravenous equipment in modern medical practices.As these trends continue to develop, stakeholders in the Intravenous Equipment Market are likely to see shifts in demand and opportunities for growth.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Intravenous Equipment Market Drivers**

### **Rising Prevalence of Chronic Diseases**

The Intravenous Equipment Market is witnessing significant growth driven by the increasing prevalence of chronic diseases, including diabetes, cancer, and cardiovascular diseases. As these conditions require long-term treatment, intravenous therapy becomes a critical component of patient care. With advancements in medical technology and devices, there is a growing trend toward the use of intravenous equipment in both hospital and outpatient settings.This increased reliance on IV therapy is pushing healthcare providers to invest in new and improved intravenous equipment to enhance patient outcomes and ensure efficient administration of medications and fluids. 

Additionally, the growing elderly population, which is more susceptible to various health conditions, contributes to the rising demand for intravenous treatments. The Intravenous Equipment Market Industry is thus positioned for sustained growth as healthcare systems adapt to meet the needs of patients with chronic illnesses.Furthermore, the focus on developing advanced intravenous systems and accessories that offer ease of use and improved safety is likely to bolster market expansion. The transition towards home healthcare and outpatient services is also encouraging the adoption of user-friendly intravenous devices that can be utilized outside traditional settings, further broadening the market landscape.

### **Technological Advancements in IV Devices**

Technological innovations in intravenous equipment are transforming the Intravenous Equipment Market Industry significantly. The introduction of smart IV systems, infusion pumps, and integrated monitoring devices has improved the safety and efficiency of intravenous therapies. These advancements enable healthcare providers to manage patient care better, reduce medication errors, and enhance the overall quality of treatment. As technology continues to evolve, there is an increasing focus on developing products that cater to the growing demand for precision in drug delivery and personalized medicine.

### **Growth of the Healthcare Sector**

The expansion of the global healthcare sector is a fundamental driver of the Intravenous Equipment Market Industry. Increased government spending, rising health awareness, and improving access to medical facilities contribute to the overall growth of healthcare services. Enhanced healthcare infrastructure, particularly in emerging economies, is driving up the demand for advanced intravenous equipment. With more hospitals and clinics being established, the need for reliable and efficient IV systems becomes paramount.

## **Intravenous Equipment Market Segment Insights**

### **Intravenous Equipment Market Type Insights  **

The Intravenous Equipment Market exhibits notable diversity within its Type segment, characterized by various essential components, including Infusion Pumps, IV Catheters, IV Administration Sets, Needles, and IV Containers.

In 2023, the market for Intravenous Equipment was valued at approximately 29.63 billion USD, reflecting a steady demand for intravenous solutions in healthcare settings. The Infusion Pumps segment leads with a market value of 8.14 billion USD, anticipated to grow to 11.3 billion USD by 2032, showcasing the critical role of these devices in delivering precise medication and fluids to patients.This segment holds a majority stake, clearly dominating the market due to its essential function in therapeutic applications.

Following closely, the IV Catheters segment recorded a market value of 6.87 billion USD in 2023 and is projected to reach 9.9 billion USD by 2032, indicating their significant role in patient care by facilitating easy access to veins for medication administration. 

IV Administration Sets contributed a solid value of 5.62 billion USD in 2023, with expected growth to 7.9 billion USD by 2032. These sets are vital in the safe and efficient administration of fluids, thereby further ensuring patient safety and comfort.On the other hand, the Needles segment held a value of 4.89 billion USD in 2023, projected to rise to 6.8 billion USD by 2032. This segment, while smaller, remains essential as needles serve as fundamental tools in various medical procedures.

Lastly, IV Containers, valued at 4.11 billion USD in 2023 and expected to reach 5.6 billion USD in 2032, are crucial in safely storing and delivering IV solutions. Each of these components not only contributes significantly to the Intravenous Equipment Market revenue but also highlights the increasing reliance on intravenous therapies in modern medical practice.However, the sector faces challenges such as regulatory hurdles and concerns regarding the safety and efficacy of intravenous products. Overall, the Intravenous Equipment Market segmentation underscores distinct opportunities for innovation and expansion within a dynamic market landscape.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Intravenous Equipment Market Application Insights  **

The Intravenous Equipment Market is primarily driven by applications that span critical healthcare needs. In 2023, the market was valued at 29.63 USD billion and was poised for growth due to increasing demand in areas such as chemotherapy, pain management, antibiotic therapy, fluid resuscitation, and nutritional support. Each application plays a crucial role; for instance, [chemotherapy](../../../reports/chemotherapy-market-5791) is essential for cancer treatment, necessitating reliable intravenous systems for administration. Pain management continues to see significant use of intravenous equipment, providing effective relief in various medical conditions.

Antibiotic therapy is vital in combating infections, hence increasingly relying on intravenous methods to ensure swift delivery. Fluid resuscitation is significant in emergency care, particularly in trauma situations, while nutritional support is a growing area, especially in patients unable to consume food orally. These dynamics showcase the vital segments within the Intravenous Equipment Market, and the market is projected to reach 41.5 USD billion by 2032, reflecting an evolving landscape with opportunities for growth driven by technological advancements and a rising prevalence of chronic diseases as indicated by Intravenous Equipment Market data and statistics.

### **Intravenous Equipment Market End-Use Insights  **

The Intravenous Equipment Market has a well-defined segmentation based on End Use, which plays a crucial role in driving its revenue potential. In 2023, the overall market was valued at 29.63 billion USD, with hospitals being a major contributor, benefiting from the high demand for intravenous therapies in critical and acute care settings. Ambulatory Surgical Centers also hold a significant share, offering convenience for patients requiring same-day procedures that often involve IV administration. Home Care Settings are an emerging area, driven by the growing trend of providing healthcare services in a patient's own home, promoting comfort and reducing hospital stays.

Specialty Clinics contribute uniquely by catering to specific patient populations, such as oncology or diabetes, where intravenous treatments are essential. The Intravenous Equipment Market statistics show that as healthcare continues to evolve, these segments present numerous opportunities for growth, driven by an increase in chronic diseases and advancements in IV therapy technologies. Additionally, the market faces challenges such as regulatory requirements and cost pressures, which may influence the overall dynamics but also pave the way for innovation and improvements in service delivery.

### **Intravenous Equipment Market Technology Insights  **

The market’s segmentation showcases the prominence of various systems, with the Electromechanical Pumps representing a substantial portion due to their precision and efficiency in delivering medication. Gravity Infusion Systems continue to be widely utilized, especially in settings where straightforward administration is necessary, allowing for effective and cost-efficient care in many healthcare environments.Meanwhile, Smart IV Therapy Systems are increasingly gaining importance, integrating technology and connectivity features that enhance patient safety and treatment efficacy. This trend towards automation and smart solutions is reshaping the landscape of the industry. 

The expected growth in the Intravenous Equipment Market data highlights an evolving market that responds to clinician needs and patient safety, providing ample opportunities for innovation in design and function. As technology continues to advance, the Intravenous Equipment Market Statistics suggest that these equipment types will play a crucial role in optimizing intravenous therapies and improving patient outcomes.

### **Intravenous Equipment Market Regional Insights  **

The Intravenous Equipment Market is valued at 29.63 USD Billion in 2023 and is set for considerable growth within the regional segmentation. North America dominates this market with a substantial valuation of 12.5 USD Billion, reflecting its majority holding and advanced healthcare infrastructure, projected to reach 18.0 USD Billion by 2032. Europe follows closely, with a significant valuation of 8.5 USD Billion in 2023, which is anticipated to grow to 11.5 USD Billion, driven by increasing chronic diseases and an aging population. 

The APAC region is valued at 6.5 USD Billion and is projected to grow to 8.5 USD Billion, attributed to rising healthcare investments and demand for intravenous therapies.South America and MEA represent smaller segments, valued at 1.5 USD Billion and 0.6 USD Billion, respectively in 2023, with growth to 2.5 USD Billion and 1.0 USD Billion by 2032. These regions offer opportunities for market expansion led by improving healthcare access and rising disposable incomes. The Intravenous Equipment Market statistics highlight varied growth drivers, but the challenges of regulatory hurdles and competition remain prevalent across all regions.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Intravenous Equipment Market Key Players and Competitive Insights**

The Intravenous Equipment Market is characterized by a dynamic competitive landscape marked by the presence of several key players that strive to innovate and enhance their product offerings to cater to the evolving needs of healthcare providers and patients. This market encompasses a range of products that are essential for intravenous therapy, including IV bags, catheters, and infusion pumps, and it is driven by factors such as a growing prevalence of chronic diseases, advancements in technology, and an increasing need for effective patient management systems.

The competitive insights in this sector reveal a continuous emphasis on product development, strategic collaborations, mergers, and acquisitions, enabling companies to expand their market reach while enhancing patient safety and therapeutic outcomes. 

Braun Melsungen holds a significant position in the Intravenous Equipment Market, bolstered by its extensive product portfolio and a strong focus on innovation. The company's strengths lie in its comprehensive range of IV solutions, which cater to various medical needs, making it a reliable partner for healthcare institutions. B. Braun Melsungen invests heavily in research and development, ensuring that the latest technologies and best practices are incorporated into their products. Furthermore, the company's commitment to quality and safety is evident in its rigorous adherence to regulatory standards and certifications.

This focus not only instills confidence among healthcare professionals but also positions B. Braun Melsungen as a leader in the market, consistently addressing challenges related to intravenous therapy while improving patient care.

Cardinal Health is another prominent entity in the Intravenous Equipment Market, recognized for its comprehensive distribution network and extensive range of intravenous products. The company benefits from a robust infrastructure that allows it to efficiently deliver essential IV supplies to healthcare providers. Cardinal Health's unique strength lies in its ability to integrate analytics and technology into its operations, enabling healthcare facilities to optimize their supply chains and improve patient outcomes. The company's focus on custom solutions further enhances its value proposition, allowing it to cater to the specific needs of different healthcare providers.

By continuously enhancing its product offerings and leveraging its market presence, Cardinal Health plays a crucial role in shaping the future of intravenous therapy while maintaining high standards of quality and reliability within the industry.

### **Key Companies in the Intravenous Equipment Market Include**

- **[Braun Melsungen](https://catalogs.bbraun.com/en-01/c/PRODUCTS0000000585/iv-administration-sets)**
- Cardinal Health
- IV Solutions
- Medtronic
- Vygon
- Terumo Corporation
- Nipro Corporation
- R. Bard
- Fresenius Kabi
- Baxter International
- Haemonetics
- AMEDTEC Medizintechnik
- AngioDynamics
- MediPoint
- Smiths Medical

## Intravenous Equipment Industry Developments

- **Q2 2025: BD Launches HemoSphere Alta Platform with AI-Driven Decision Support for Critical-Care Hemodynamics** BD announced the launch of its HemoSphere Alta platform, which integrates AI-driven decision support to enhance critical-care hemodynamics monitoring, expanding its intravenous equipment portfolio.
- **Q2 2025: Teleflex Secures FDA 510(k) Clearance for the AC3 Range Intra-Aortic Balloon Pump** Teleflex received FDA 510(k) clearance for its AC3 Range intra-aortic balloon pump, a device used in intravenous therapy for critical cardiac care.
- **Q1 2025: Merck’s subcutaneous pembrolizumab met non-inferiority versus IV dosing in Phase 3 trial** Merck announced positive Phase 3 trial results for subcutaneous pembrolizumab, demonstrating non-inferiority compared to intravenous dosing, which may impact future IV equipment demand.

## **Intravenous Equipment Market Segmentation Insights**

### **Intravenous Equipment Market Type Outlook**

- Infusion Pumps
- IV Catheters
- IV Administration Sets
- Needles
- IV Containers 

### **Intravenous Equipment Market Application Outlook**

- Chemotherapy
- Pain Management
- Antibiotic Therapy
- Fluid Resuscitation
- Nutritional Support 

### **Intravenous Equipment Market End-Use Outlook**

- Hospitals
- Ambulatory Surgical Centers
- Home Care Settings
- Specialty Clinics 

### **Intravenous Equipment Market Technology Outlook**

- Electromechanical Pumps
- Gravity Infusion Systems
- Smart IV Therapy Systems 

### **Intravenous Equipment Market Regional Outlook**

- North America
- Europe
- South America
- Asia-Pacific
- Middle East and Africa

## Market Drivers

### 医疗支出上升

医疗支出的上升趋势是静脉设备市场的重要驱动因素。随着各国将更多资源分配给医疗保健，对先进医疗技术（包括静脉设备）的需求可能会增加。数据显示，预计未来几年医疗支出将大幅上升，推动因素包括老龄化人口和对改善医疗服务的需求。这一支出增加使医疗机构能够投资于最先进的静脉设备，增强治疗能力和患者护理。此外，更高的医疗预算通常会导致医疗基础设施的扩展，这进一步刺激了对静脉治疗的需求。因此，静脉设备市场将从这一趋势中受益，因为对医疗保健的投资增加意味着静脉解决方案的使用量也会增加。

### 监管支持和标准

监管支持和严格标准的建立在塑造静脉注射设备市场中至关重要。监管机构越来越关注确保静脉注射产品的安全性和有效性，这增强了消费者信心并推动了市场增长。例如，静脉注射设备设计和制造指南的实施提高了产品质量和安全性。这种监管环境鼓励行业的创新和投资，因为公司努力满足合规要求。此外，对患者安全和质量保证的重视可能会导致对认证静脉注射设备的需求增加。随着医疗服务提供者优先使用合规产品，静脉注射设备市场预计将受益于这一支持性的监管环境，从而促进其增长轨迹。

### 慢性疾病的发病率上升

慢性疾病（如糖尿病、癌症和心血管疾病）的日益普遍是静脉设备市场的主要驱动因素。由于这些疾病通常需要长期治疗和管理，静脉治疗的需求激增。根据最近的数据，慢性疾病约占全球所有死亡人数的70%，这就需要有效的治疗选择。这一趋势可能会推动静脉设备行业的增长，因为医疗服务提供者寻求可靠和高效的解决方案来施用药物和液体。此外，老龄化人口对这些疾病更为敏感，进一步加大了对先进静脉设备的需求。因此，静脉设备市场有望实现显著增长，因为医疗系统正在适应以满足对慢性疾病管理日益增长的需求。

### 静脉输液设备中的技术创新

静脉设备的技术进步正在显著影响静脉设备市场。智能输液泵、无针系统和自动化静脉系统等创新提高了静脉治疗的效率和安全性。例如，配备剂量错误减少系统的智能输液泵可以最小化用药错误，这在医疗环境中是一个关键问题。仅输液泵市场预计到2026年将达到数十亿美元，反映出对技术的日益依赖，以改善患者的治疗结果。此外，远程医疗与静脉治疗的结合正在出现，允许对患者进行远程监测和管理。这种技术与医疗的融合可能会推动对先进静脉设备的需求，使静脉设备市场持续扩张。

### 对家庭医疗保健解决方案的需求增加

向家庭医疗解决方案的转变正在重塑静脉设备市场。随着患者越来越倾向于在家中舒适地接受护理，对便携式和用户友好的静脉设备的需求正在上升。这一趋势得到了对以患者为中心的护理和成本效益治疗方案日益重视的支持。数据显示，家庭医疗市场预计将显著增长，其中相当一部分增长归因于静脉治疗。家庭医疗不仅减少了医院再入院率，还提高了患者满意度。因此，制造商正专注于开发适合家庭使用的静脉设备，如轻便的输液泵和易于使用的给药装置。这种护理交付的演变可能会推动静脉设备市场向前发展，因为它适应了家庭医疗的需求。

## Future Outlook

静脉设备市场预计将在2024年至2035年间以3.82%的年均增长率增长，推动因素包括技术进步、医疗需求增加和慢性疾病上升。

**New opportunities:**

- 开发集成监测系统的智能静脉输液泵。 扩展远程静脉治疗管理的远程医疗服务。 投资可生物降解的静脉输液组件，以增强可持续发展努力。

到2035年，市场预计将实现强劲增长，反映出不断变化的医疗需求和技术创新。

## Segment Insights

### 按类型：输液泵（最大）与静脉导管（增长最快）

在静脉输液设备市场中，各个细分市场的份额分布具有独特的特点。输液泵作为最大的细分市场，因其在药物输送中的精确性和效率而受到青睐。紧随其后的是静脉导管，因其在外科和门诊环境中的多功能性和在静脉治疗中的重要作用而显示出显著的需求。静脉给药装置、针头和静脉容器也对市场有所贡献，尽管其市场份额相对较低，代表了静脉设备中至关重要但不那么主导的方面。

输液泵（主导）与静脉给药系统（新兴）

输液泵在静脉设备市场中至关重要，主要由于其创新技术和确保在较长时间内准确输送药物的能力。它们拥有强大的市场地位，受到技术进步和对患者安全日益重视的推动。相反，静脉给药系统被视为新兴产品，随着医疗系统寻求提高效率和减少浪费而获得关注。尽管传统上被泵所掩盖，但材料和设计的进步使这些系统对医疗提供者更具吸引力，促进了日益增长的兴趣和不断发展的市场存在。

### 按应用：化疗（最大）与疼痛管理（增长最快）

在静脉注射设备市场中，应用领域多样，包括化疗、疼痛管理、抗生素治疗、液体复苏和营养支持等。其中，化疗在该领域占据最大份额，因为它在癌症治疗中发挥着关键作用，利用静脉注射设备进行精确的药物输送。紧随其后的是疼痛管理，尤其是随着越来越多的患者寻求有效的疼痛控制方法，推动了对专业静脉注射设备的需求。

化疗（主导）与疼痛管理（新兴）

化疗在静脉设备市场的应用领域中占据主导地位，因为它在癌症治疗中被广泛使用，而精确的剂量和时机至关重要。用于化疗的设备通常是专门设计的，以防止并发症，确保患者安全和有效的药物输送。另一方面，疼痛管理正在强劲崛起，特别是在术后护理和慢性疼痛场景中。创新的静脉疼痛管理解决方案正在迅速发展，越来越关注患者的体验和结果。这一动态转变在很大程度上是由于对疼痛管理疗法的认识和接受度的提高，以及静脉技术的进步，这些进步提高了疗效并减少了副作用。

### 按最终用途：医院（最大）与居家护理环境（增长最快）

在静脉设备市场中，医院占据了最大的份额，继续主导该行业，因为它们拥有广泛的患者基础和复杂的治疗需求。门诊手术中心和专科诊所也发挥着重要作用，但它们的份额相对较小。虽然家庭护理环境之前较小，但随着技术的进步和护理向患者便利性和自主性的转变，正在显著增加。该细分市场的增长趋势受到老年人口增加、慢性疾病患病率上升以及向门诊护理转变的推动。家庭护理环境提供的效率和舒适性是其快速扩展的重要因素。随着医疗服务模式的演变，各种环境对静脉设备的需求预计将继续上升。

医院（主导）与居家护理环境（新兴）

医院仍然是静脉设备市场的主导部分，广泛被认可为对先进静脉治疗和重症护理的需求。他们需要各种静脉设备，如输液泵和导管，以安全有效地向多样化的患者群体提供药物和液体。相反，家庭护理环境正在成为一个重要力量，受到以患者为中心的护理趋势和远程监测及输液系统技术创新的推动。患者更喜欢在家中接受护理的舒适和熟悉感，这导致对满足他们特定需求的设备的投资增加。这一转变表明，两个领域都必须适应不断变化的患者期望和医疗政策。

### 按技术分类：电机泵（最大）与智能静脉输液系统（增长最快）

在静脉注射设备市场中，技术细分展示了一系列多样化的产品，电机驱动泵因其可靠性和在医疗环境中的广泛应用而占据市场份额的领先地位。这些泵因其在液体输送中的精确性而受到医疗专业人员的青睐。智能静脉治疗系统虽然目前市场份额较小，但由于技术的进步，能够改善监测和患者安全功能，正在迅速获得关注。

技术：电机械泵（主导）与智能静脉输液系统（新兴）

电动机械泵在静脉输液设备技术领域占据主导地位，因其准确性和用户友好的界面而受到青睐。它们满足各种临床需求，确保流体和药物的一致输送。相比之下，智能静脉治疗系统被视为一种新兴技术，集成了基于人工智能的分析和实时监测，以增强患者护理。由于医疗行业对患者安全和效率的关注，它们的快速采用使其成为静脉治疗未来的重要参与者。

## Regional Market Share Analysis

### 北美：创新的市场领导者

北美是静脉设备最大的市场，约占全球市场份额的40%。该地区的增长受到先进医疗基础设施、慢性疾病患病率上升以及对患者安全法规的高度重视的推动。对创新IV解决方案的需求进一步受到技术进步和手术程序数量增加的推动。像FDA这样的监管机构在确保产品安全性和有效性方面发挥着至关重要的作用，促进了竞争环境。美国是该市场的领先国家，其次是加拿大。巴克斯特国际公司、史密斯医疗和ICU医疗公司等主要参与者主导着市场，专注于产品创新和战略合作伙伴关系。竞争格局由一系列成熟公司和新兴参与者组成，所有这些公司都在努力通过先进的静脉解决方案提升患者护理。主要参与者的存在确保了强大的供应链和新技术的持续发展。

### 欧洲：具有增长潜力的新兴市场

欧洲是静脉设备第二大市场，约占全球市场份额的30%。该地区的增长受到老龄化人口、医疗支出增加和慢性疾病发生率上升的推动。医疗器械法规（MDR）等监管框架正在提高产品的安全性和有效性，从而推动市场需求。德国和法国等国处于市场前沿，为市场的扩展做出了重要贡献。德国在欧洲市场中处于领先地位，其次是法国和英国。竞争格局中有B. Braun Melsungen AG和费森尤斯卡比AG等主要参与者，他们正在投资研发以创新其产品。成熟的医疗系统和改善患者结果的关注进一步增强了市场。制造商与医疗提供者之间的合作对于满足患者和医疗系统不断变化的需求至关重要。

### 亚太地区：快速增长的医疗保健部门

亚太地区的静脉设备市场正在迅速增长，约占全球市场份额的20%。该地区的扩展受到医疗投资增加、人口增长和对先进医疗技术认识提高的推动。中国和印度等国在这一增长中处于领先地位，得益于政府旨在改善医疗基础设施和医疗服务可及性的举措。随着医疗设施的扩展和现代化，对静脉设备的需求预计将激增。中国是该地区最大的市场，其次是印度和日本。竞争格局变得越来越动态，本地和国际参与者都在争夺市场份额。特鲁莫公司和美敦力公司等主要公司专注于战略合作伙伴关系和产品创新，以满足日益增长的需求。多样化制造商的存在确保了竞争环境，推动了静脉技术的进步并改善了患者护理。

### 中东和非洲：具有潜力的未开发市场

中东和非洲地区是静脉设备的新兴市场，约占全球市场份额的10%。增长受到医疗投资增加、慢性疾病患病率上升和改善医疗基础设施的关注增加的推动。南非和阿联酋等国在市场中处于领先地位，得益于政府旨在提高医疗可及性和质量的举措。随着医疗设施的扩展和现代化，对静脉设备的需求预计将上升。南非是该地区最大的市场，其次是阿联酋。竞争格局由本地和国际参与者混合组成，Halyard Health, Inc.和Vygon S.A.等公司正在取得显著进展。主要参与者的存在对于满足医疗系统不断变化的需求至关重要，制造商与医疗提供者之间的合作对于推动创新和改善患者结果至关重要。

## Competitive Benchmarking

静脉设备市场目前的特点是动态的竞争格局，受到对先进医疗技术需求增加和对患者安全日益重视的推动。关键参与者如巴克斯国际公司（美国）、B. Braun Melsungen AG（德国）和费森尤斯卡比公司（德国）在战略上定位以利用创新并扩大市场份额。巴克斯国际公司（美国）专注于通过技术进步增强其产品组合，而B. Braun Melsungen AG（德国）则强调区域扩张和合作伙伴关系，以巩固其在新兴市场的立足点。费森尤斯卡比公司（德国）似乎优先考虑可持续性和数字化转型，这共同塑造了一个越来越关注质量和效率的竞争环境。

市场结构适度分散，多个参与者通过各种商业策略争夺市场份额。公司正在本地化生产以降低成本并优化供应链，这在维持竞争定价和确保及时交付产品方面至关重要。这些关键参与者的集体影响力促进了一个竞争氛围，在这里创新和运营效率至关重要，使他们能够迅速响应市场需求和监管变化。

2025年8月，史密斯医疗（美国）宣布推出一系列新的智能输液泵，旨在提高药物输送的准确性。这一战略举措具有重要意义，因为它与日益增长的数字健康解决方案趋势相一致，可能改善患者结果并减少用药错误。通过投资智能技术，史密斯医疗（美国）将自己定位为输液市场的领导者，以满足对医疗服务精确度日益增长的需求。

2025年9月，Terumo Corporation（日本）在东南亚扩大了其制造能力，旨在满足该地区对静脉设备日益增长的需求。这一扩张在战略上具有重要意义，因为它不仅增强了Terumo的生产能力，还允许更快地响应当地市场需求。这种区域投资表明对本地化供应链的承诺，而本地化供应链在竞争激烈的市场中变得越来越重要。

2025年10月，ICU Medical, Inc.（美国）与一家领先的远程医疗提供商达成战略合作伙伴关系，将远程监测能力整合到其静脉系统中。这一合作表明了医疗保健技术整合的更广泛趋势，暗示ICU Medical, Inc.（美国）希望通过数字解决方案增强其产品供应。这一举措可能重新定义患者护理，使医疗提供者能够更有效地监测患者，从而改善整体治疗结果。

截至2025年10月，静脉设备市场的竞争趋势越来越受到数字化、可持续性和人工智能整合的定义。战略联盟正在塑造市场格局，使公司能够汇聚资源和专业知识，更有效地进行创新。展望未来，竞争差异化可能会从传统的基于价格的竞争演变为关注创新、技术进步和供应链可靠性，因为公司努力满足现代医疗的复杂需求。

## Recent News & Developments

- **2025年第二季度：BD推出HemoSphere Alta平台，提供基于AI的决策支持以改善危重护理血流动力学** BD宣布推出其HemoSphere Alta平台，该平台集成了基于AI的决策支持，以增强危重护理血流动力学监测，扩展其静脉设备组合。
- **2025年第二季度：Teleflex获得FDA 510(k)批准，推出AC3系列主动脉内球囊泵** Teleflex获得FDA 510(k)批准，推出其AC3系列主动脉内球囊泵，这是一种用于危重心脏护理的静脉治疗设备。
- **2025年第一季度：默克的皮下给药pembrolizumab在第三阶段试验中显示与静脉给药的非劣效性** 默克宣布皮下给药pembrolizumab的第三阶段试验结果积极，显示与静脉给药相比具有非劣效性，这可能会影响未来静脉设备的需求。

## Report Scope

| 2024年市场规模 | 31.94（十亿美元） |
| --- | --- |
| 2025年市场规模 | 33.16（十亿美元） |
| 2035年市场规模 | 48.25（十亿美元） |
| 年复合增长率（CAGR） | 3.82%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 智能技术在静脉注射设备中的整合增强了患者监测和安全性。 |
| 主要市场动态 | 技术进步和监管变化推动静脉注射设备市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，静脉注射设备市场的预计市场估值是多少？**
A: 预计到2035年，静脉注射设备市场的市场估值将达到482.5亿美元。

**Q: 2024年静脉注射设备市场的整体市场估值是多少？**
A: 2024年静脉输液设备市场的整体市场估值为319.4亿美元。

**Q: 在2025年至2035年的预测期内，静脉注射设备市场的预期CAGR是多少？**
A: 预计2025年至2035年期间，静脉设备市场的年均增长率（CAGR）为3.82%。

**Q: 到2035年，预计在静脉设备市场中哪个细分市场的估值最高？**
A: 营养支持部门预计到2035年将达到157.5亿美元的估值。

**Q: 静脉输液设备市场的关键参与者有哪些？**
A: 静脉设备市场的主要参与者包括巴克斯国际公司、B. Braun Melsungen AG 和费森尤斯卡比公司。

**Q: 到2035年，输液泵部门预计将增长多少？**
A: 输液泵细分市场预计将从2024年的80亿美元增长到2035年的120亿美元。

**Q: 到2035年，IV导管细分市场的预计估值是多少？**
A: 预计到2035年，IV导管部门的估值将达到100亿美元。

**Q: 到2035年，预计哪个最终用途细分市场将主导市场？**
A: 医院终端使用细分市场预计将主导市场，到2035年达到180亿美元。

**Q: 到2035年，智能静脉治疗系统的预期增长是多少？**
A: 智能静脉治疗系统预计将从2024年的139.4亿美元增长到2035年的212.5亿美元。

**Q: 在静脉设备市场中，预计哪个应用领域将看到最大的增长？**
A: 流体复苏应用领域预计将从2024年的80亿美元增长到2035年的110亿美元。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/intravenous-equipment-market-32694*